The immunoregulatory gene cx3cl1 emerges as a prominent constituent in the inflammatory milieu of ccRCC, bestowing a pathway to personalized treatment strategies.39 The gene discussed is CX3CL1; the disease is nonpapillary renal cell carcinoma.